Thermo Fisher Scientific (TMO) Total Liabilities (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Total Liabilities for 18 consecutive years, with $60.5 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities rose 19.18% year-over-year to $60.5 billion; the trailing twelve-month figure through Jun 2026 stood at $60.5 billion (up 19.18% YoY), and the FY2025 full-year result was $56.9 billion, up 19.17% from the prior year.
• Total Liabilities eased to $60.5 billion in Q2 2026 per TMO's latest filing, from $61.3 billion in the prior quarter.
• Across five years, Total Liabilities topped out at $61.3 billion in Q1 2026 and bottomed at $46.9 billion in Q4 2022.
• Historically, Total Liabilities has averaged $52.2 billion across 5 years, with a median of $51.7 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities surged 67.61% in 2022, then retreated 8.14% in 2024.
• Over 5 years, Total Liabilities stood at $53.1 billion in 2022, then fell by 2.11% to $52.0 billion in 2023, then slipped by 8.14% to $47.8 billion in 2024, then rose by 19.17% to $56.9 billion in 2025, then gained by 6.25% to $60.5 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $60.5 billion, $61.3 billion, and $56.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.